SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-20-000445
Filing Date
2020-02-18
Accepted
2020-02-18 17:10:36
Documents
9
Period of Report
2020-02-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c95292_8k.htm 8-K 15095
2 c95292_ex99-1.htm EX-99.1 16538
3 GRAPHIC image_001.jpg GRAPHIC 68827
4 GRAPHIC image_002.jpg GRAPHIC 419791
5 GRAPHIC image_003.jpg GRAPHIC 316146
6 GRAPHIC image_008.jpg GRAPHIC 213631
7 GRAPHIC image_005.jpg GRAPHIC 245524
8 GRAPHIC image_006.jpg GRAPHIC 407902
9 GRAPHIC image_007.jpg GRAPHIC 84199
  Complete submission text file 0000930413-20-000445.txt   2451933
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 20626315
SIC: 8071 Services-Medical Laboratories